Abstract
We constructed an ERS signature as a novel prognostic marker for predicting survival in sepsis patients, which could be used to develop novel biomarkers for the diagnosis, treatment, and prognosis of sepsis and to provide new ideas and prospects for future clinical research.
Introduction
Sepsis remains a critical global health challenge, characterized by a systemic inflammatory response to infection that frequently leads to multi-organ failure and high mortality rates. With over 30 million cases annually, there is an urgent clinical need for precise prognostic tools to identify patients at high risk of deterioration. This study explores the role of Endoplasmic Reticulum Stress (ERS)—a cellular state where the protein-folding capacity of the ER is overwhelmed—as a molecular basis for predicting sepsis outcomes.
Methodology and Model Construction
The researchers employed a multi-stage bioinformatics pipeline to identify a robust genetic signature. The process began with a differential expression analysis comparing healthy controls to sepsis patients to identify genes that behave differently during infection.
Following the identification of DEGs, the team used:
- Univariate Cox Regression: To filter genes significantly associated with patient survival.
- LASSO Regression: To minimize overfitting and select the most impactful features.
- Multivariate Cox Regression: To establish a final 10-gene risk score formula involving ADRB2, DHCR7, GABARAPL2, MAOA, MPO, PDZD8, QDPR, SCAP, TFRC, and TLR4.
The model was trained on the GSE65682 dataset (n=288) and validated internally (n=191) and externally (GSE95233, n=51).
Biological Insights: The ERS-Immune Axis
The study revealed that the 10-gene signature is deeply integrated with the patient's immune landscape. High-risk patients exhibited distinct immune profiles, notably lower levels of CD8+ T cells and higher levels of unpolarized M0 macrophages, suggesting that ERS may contribute to immune exhaustion.
The functional enrichment analysis highlighted that these genes are involved in critical pathways, including neutrophil activation and ribosome biogenesis, bridging the gap between cellular stress and systemic immune response.
Key Results
The ERS-based signature demonstrated strong predictive performance:
- Prognostic Accuracy: The 10-gene signature alone achieved an AUC (Area Under the Curve) of approximately 0.80 in both training and internal validation sets.
- Clinical Integration: A nomogram combining the genetic risk score with clinical variables (age, gender, pneumonia status) reached an impressive AUC of 0.871 for 5-day survival.
- Risk Stratification: The model effectively stratified patients into high- and low-risk groups, with the low-risk cohort showing significantly better 28-day survival rates.
Conclusion and Future Directions
This ERS-related gene signature provides a promising molecular "weather forecast" for sepsis management. While the retrospective nature of the study and the focus on a single pathway are limitations, the high accuracy of the integrated nomogram suggests significant potential for clinical application. Future prospective trials are necessary to validate these findings and explore the mechanistic roles of specific genes in sepsis pathology.
Summary updated